Skip to main content

Find Drugs & Conditions

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

FDA Approves Enbumyst (bumetanide) Nasal Spray for the Treatment of Edema Associated with Congestive Heart Failure, Liver Disease and Kidney Disease

(BUSINESS WIRE) September 15, 2025 --Corstasis Therapeutics Inc., an innovative biopharmaceutical company providing enhanced outpatient therapeutic options...

Intercept Announces Voluntary Withdrawal of Ocaliva for Primary Biliary Cholangitis (PBC) from the US Market; FDA Places US Clinical Trials on Hold

September 12, 2025. MORRISTOWN, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc., a wholly owned biopharmaceutical subsidiary...

FDA Approves Selumetinib for Pediatric Patients 1 year of Age and Older with Neurofibromatosis Type 1 with Symptomatic, Inoperable Plexiform Neurofibromas

On September 10, 2025, the Food and Drug Administration approved selumetinib (Koselugo, AstraZeneca Pharmaceuticals LP) granules and capsules for pediatric...

FDA Approves Inlexzo (gemcitabine intravesical system) for the Treatment of Non-Muscle Invasive Bladder Cancer

September 9, 2025. RARITAN, N.J., September 9, 2025 /PRNewswire/ – Johnson & Johnson (NYSE:JNJ) announced today the U.S. Food and Drug Administration...

Parental Diseases of Despair Linked to Suicidal Events in Offspring

Parental diseases of despair (DoD; i.e., substance use disorder, alcohol-related disease, or suicidal behavior) are associated with suicidal events (SE)...

Childhood Loneliness Linked to Cognitive Decline in Adulthood

Childhood loneliness is associated with cognitive decline and dementia risk in adulthood, according to a study published online Sept. 12 in JAMA Network...

Globally, Diabetes Underdiagnosed, Poorly Controlled With Treatment

In 2023, 55.8 percent of those with diabetes were diagnosed, and 41.6 percent had optimal glycemic concentrations on treatment, according to a study published...

Methotrexate Cuts Systolic BP in Rheumatoid Arthritis

For patients with rheumatoid arthritis (RA), methotrexate significantly reduces systolic blood pressure (SBP), according to a study published online July...

California Votes To Ban PFAS ‘Forever Chemicals’ in Cookware, Other Items

MONDAY, Sept. 15, 2025 — Every time you reach for a nonstick pan, you could be using chemicals that are now on the chopping block in the state of...

Child in Los Angeles Dies of Rare Brain Disorder Caused by Measles

MONDAY, Sept. 15, 2025 — A child in Los Angeles County has died from a rare brain disorder caused by a measles infection in infancy, health officials...

Recall: Bariatric Fusion Vitamins Pulled for Missing Child-Safe Caps

MONDAY, Sept. 15, 2025 — About 4,700 bottles of Bariatric Fusion iron-containing multivitamins have been recalled because packaging does not meet...

Ebola Vaccinations Begin in Congo After Deadly Outbreak

MONDAY, Sept. 15, 2025 — Health workers in southern Kasai province have started giving Ebola vaccines as officials race to contain the latest outbreak,...

FDA Files Corcept’s New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer

(BUSINESS WIRE)--Sep. 10, 2025-- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development...

Greenwich LifeSciences’ GLSI-100 Granted US FDA Fast Track Designation

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01,...

'Kissing Bug' Disease Spreading in U.S., CDC Report Says

TUESDAY, Sept. 9, 2025 — Chagas disease — a potentially serious illness spread by an insect called the “kissing bug” — may...

Read more news...

Recently Added

Recently added consumer and prescribing information: Enbumyst, Inlexzo, Nuvaxovid, mNEXSPIKE, Cyklx, Papzimeos, Brinsupri, Zegfrovy, Lynozyfic, Arynta

For Consumers

For Professionals

For Researchers

Latest FDA New Drug Approvals

  • Enbumyst Enbumyst (bumetanide) nasal spray is a loop diuretic indicated for the treatment of edema associated with congestive heart failure, hepatic...
  • Ocaliva Ocaliva (obeticholic acid) is a first-in-class farnesoid X receptor (FXR) agonist for the treatment of primary biliary cholangitis.
  • Inlexzo Inlexzo (gemcitabine intravesical system) is a treatment for certain patients with BCG-unresponsive non-muscle invasive bladder cancer

More FDA approvals